Symptomatic hypocalcemia due to oral risedronate therapy.
Dogru
Teoman
T
Sonmez
A
A
Tasci
I
I
Genc
H
H
D000328:Adult; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002446:Celiac Disease / Q000150:complications / Q000188:drug therapy; D012968:Etidronic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology; D000068296:Risedronic Acid
D050071:Bone Density Conservation Agents; D000068296:Risedronic Acid; D012968:Etidronic Acid